Selective activation of Kir2.1 channels by PI(4,5)P2 involves orientational specificity, and other PIPs inhibit this activation through direct competition.
Clarifies PIP selectivity for Kir2.1; extends molecular models of channel regulation but leaves clinical translation open.
Kir2.1 channels are uniquely activated by phosphoinositide 4,5-bisphosphate (PI(4,5)P2) and can be inhibited by other phosphoinositides (PIPs). Using biochemical and computational approaches, we assess PIP-channel interactions and distinguish residues that are energetically critical for binding from those that alter PIP sensitivity by shifting the open-closed equilibrium. Intriguingly, binding of each PIP is disrupted by a different subset of mutations. In silico ligand docking indicates that PIPs bind to two sites. The second minor site may correspond to the secondary anionic phospholipid site required for channel activation. However, 96–99% of PIP binding localizes to the first cluster, which corresponds to the general PI(4,5)P2 binding location in recent Kir crystal structures. PIPs can encompass multiple orientations; each di- and triphosphorylated species binds with comparable energies and is favored over monophosphorylated PIPs. The data suggest that selective activation by PI(4,5)P2 involves orientational specificity and that other PIPs inhibit this activation through direct competition.Background: Kir2.1 channels are uniquely activated by PI(4,5)P2 and can be inhibited by other PIPs.Results: A different subset of residues controls channel binding to each PIP. PIPs can encompass multiple orientations in two sites.Conclusion: Selective activation by PI(4,5)P2 involves orientational specificity, and other PIPs inhibit through direct competition.Significance: Our findings reveal unanticipated complexities of PIP interactions. Kir2.1 channels are uniquely activated by phosphoinositide 4,5-bisphosphate (PI(4,5)P2) and can be inhibited by other phosphoinositides (PIPs). Using biochemical and computational approaches, we assess PIP-channel interactions and distinguish residues that are energetically critical for binding from those that alter PIP sensitivity by shifting the open-closed equilibrium. Intriguingly, binding of each PIP is disrupted by a different subset of mutations. In silico ligand docking indicates that PIPs bind to two sites. The second minor site may correspond to the secondary anionic phospholipid site required for channel activation. However, 96–99% of PIP binding localizes to the first cluster, which corresponds to the general PI(4,5)P2 binding location in recent Kir crystal structures. PIPs can encompass multiple orientations; each di- and triphosphorylated species binds with comparable energies and is favored over monophosphorylated PIPs. The data suggest that selective activation by PI(4,5)P2 involves orientational specificity and that other PIPs inhibit this activation through direct competition. Background: Kir2.1 channels are uniquely activated by PI(4,5)P2 and can be inhibited by other PIPs. Results: A different subset of residues controls channel binding to each PIP. PIPs can encompass multiple orientations in two sites. Conclusion: Selective activation by PI(4,5)P2 involves orientational specificity, and other PIPs inhibit through direct competition. Significance: Our findings reveal unanticipated complexities of PIP interactions.
No takes yet. Share an insight, caveat, or question.
D’Avanzo et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: